Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Tonsillectomy
Condition(s) studied
Investigational drug(s) / intervention(s)
Ondansetron lozenge: Patients will receive ondansetron lozenge 4 mg (Ondalenz ©), 2 hours before surgery.
Ondansetron intravenous: Patients will receive 4 mg of ondansetron IV just before the surgery.
Study summary
This study aims to compare the effect of ondansetron lozenge and intravenous for prevention of shivering in tonsillectomy.
Eligibility
Primary outcome measure(s)
- Incidence of shivering — 24 hours postoperatively
Incidence of shivering will be recorded and graded by using the scale validated by Crossley and Mahajan. Crossley and Mahajan grade 0, no shivering; grade 1, no visible muscle activity, but one or more of the following: piloerection, peripheral vasoconstriction, or peripheral cyanosis (other causes excluded); grade 2, muscular activity in only one muscle group; grade 3, moderate muscular activity in more than one muscle group but not generalized shaking; grade 4, violent muscular activity that involves the whole body.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Tanta University | Tanta | El-Gharbia | Recruiting |
More Tanta University trials in Egypt
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07489742 on ClinicalTrials.gov ↗ ← All trials in Egypt